Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients
Clinical trial NCT00536575 · COMPLETED
Trial details
- NCT number
- NCT00536575
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2010-02-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.